Grow Your Pharma Business Digitally
Virtual Booth
Contact Supplier
An Enquiry
Product Reset all filters
01 1Elahere
AbbVie
Mirvetuximab Soravtansine
Main Therapeutic Indication : Oncology
Currency : USD
2024 Revenue in Millions : 479
2023 Revenue in Millions : 0
Growth (%) : NA
Portfolio PDF
Product Web Link
Digital Content
Website
Corporate PDF